Literature DB >> 28617437

EMT-Regulome: a database for EMT-related regulatory interactions, motifs and network.

Zhangxiang Zhao1,2, Wenbin Zhou1, Yue Han1, Fuduan Peng1, Ruiping Wang1, Ruihan Yu1, Chengyu Wang1,2, Haihai Liang3, Zheng Guo1,4,5, Yunyan Gu1,2.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28617437      PMCID: PMC5520922          DOI: 10.1038/cddis.2017.267

Source DB:  PubMed          Journal:  Cell Death Dis            Impact factor:   8.469


× No keyword cloud information.
Dear Editor, The Epithelial-mesenchymal transition (EMT) is a fundamental cellular process that governs biological processes, such as embryonic development, tumor cell metastasis, organ fibrosis and tissue regeneration.[1] EMT allows polarized, immotile epithelial cells to transform into motile mesenchymal cells.[2] This switch is mediated by regulatory factors such as transcription factor (TF), microRNA (miRNA) and long non-coding RNA (lncRNA) at transcriptional and post-transcriptional levels.[3, 4] These regulatory factors play co-regulational roles on the EMT process and the regulatory loops act as motifs, which are the basic units in the regulatory network.[5] However, a database with comprehensive EMT regulatory relationships is still lacking. EMT-Regulome comprehensively collected the interactions between regulators and targets, including TF-target, miRNA-target, miRNA-lncRNA, TF-lncRNA and TF-miRNA and identified 10 types of co-regulation motifs for EMT process (Figure 1). EMT-Regulome provides the option for searching EMT-related regulatory interactions, motifs and networks, which facilitates the investigations of the mechanisms of EMT involved in diseases, such as tumor cell invasion. The database is freely available at http://www.medsysbio.org/EMTRegulome.
Figure 1

The flow chart of the EMT-Regulome database

In current version, EMT-Regulome contains 1740 miRNAs, 8783 lncRNAs and 13 025 coding genes, which includes 370 TF coding genes and 350 EMT-related genes (Supplementary Figure 1A). We collected regulatory relationships, including TF-targets, miRNA-targets, miRNA-lncRNA, TF-lncRNA and TF-miRNA, from public databases (Figure 1). Then, we integrated the regulation into a comprehensive network and searched 10 types of motifs that are the basic units in the regulatory network (Figure 1). Especially, for the fifth motif type, known as competing endogenous RNA (ceRNA), we used hypergeometric test to measure whether two RNA components significantly shared miRNAs. The motifs containing at least one EMT-related gene from dbEMT,[6] which collected experimentally verified EMT-related genes from literatures, were defined as EMT-related motifs in the EMT-Regulome database. The statistics of motifs are shown in Figure 1. The EMT-Regulome database provides a user-friendly interface that allows users to conveniently search, browse and download data (Supplementary Figure 2). In the ‘Search’ page, the query function can be performed using Symbol or ID of coding gene/miRNA/lncRNA with specified motif types. The search results are composed of three parts:(i) information box of gene, miRNA or lncRNA, which is offered as a search condition, including brief functional description, location in chromosome and external link to NCBI, miRBase or Ensembl for more detail; (ii) motifs are grouped by types, and source databases of their regulation are provided. (iii) returned motifs could be visualized as a network and are allowed to be exported as PNG files in various layouts by the Cytoscape web tool (http://js.cytoscape.org). As a case analysis, the EMT-Regulome database was applied to identify potential activated EMT motifs in the mesenchymal subtype of ovarian cancer by employing expression profiles from The Cancer Genome Atlas (TCGA). Yang et al.[7] have classified the TCGA ovarian cancer samples into integrated epithelial (iE) subtype and integrated mesenchymal (iM) subtype labels. Here, the activated motifs were defined as the nodes in motifs that were differentially expressed in iM compared with the iE ovarian cancer samples (T-test) and the edges in motifs were differentially co-expressed in iM type (Pearson correlation test). All the activated EMT-related motifs in ovarian cancer are available in the download page or by searching specific nodes with statistical control in search page. In conclusion, EMT-Regulome provides a comprehensive landscape of EMT-related regulation motifs to facilitate the investigation of the mechanism of EMT involved in the pathological and physiological processes. The features of EMT-Regulome include, (i) comprehensively integrated different EMT-related regulatory relationships from multiple databases; (ii) systematically provided EMT-related motifs, such as feed-forward loop and ceRNA with statistical control; (iii) all the EMT-related regulatory relationships can be visualized as network and be downloaded.
  7 in total

Review 1.  Epigenetic reprogramming and post-transcriptional regulation during the epithelial-mesenchymal transition.

Authors:  Chung-Yin Wu; Ya-Ping Tsai; Min-Zu Wu; Shu-Chun Teng; Kou-Juey Wu
Journal:  Trends Genet       Date:  2012-06-19       Impact factor: 11.639

Review 2.  Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis.

Authors:  Jing Yang; Robert A Weinberg
Journal:  Dev Cell       Date:  2008-06       Impact factor: 12.270

Review 3.  Transcription factor and microRNA co-regulatory loops: important regulatory motifs in biological processes and diseases.

Authors:  Hong-Mei Zhang; Shuzhen Kuang; Xushen Xiong; Tianliuyun Gao; Chenglin Liu; An-Yuan Guo
Journal:  Brief Bioinform       Date:  2013-12-04       Impact factor: 11.622

Review 4.  EMT: 2016.

Authors:  M Angela Nieto; Ruby Yun-Ju Huang; Rebecca A Jackson; Jean Paul Thiery
Journal:  Cell       Date:  2016-06-30       Impact factor: 41.582

5.  Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer.

Authors:  Da Yang; Yan Sun; Limei Hu; Hong Zheng; Ping Ji; Chad V Pecot; Yanrui Zhao; Sheila Reynolds; Hanyin Cheng; Rajesha Rupaimoole; David Cogdell; Matti Nykter; Russell Broaddus; Cristian Rodriguez-Aguayo; Gabriel Lopez-Berestein; Jinsong Liu; Ilya Shmulevich; Anil K Sood; Kexin Chen; Wei Zhang
Journal:  Cancer Cell       Date:  2013-02-11       Impact factor: 31.743

6.  Long non-coding RNAs (LncRNA) regulated by transforming growth factor (TGF) β: LncRNA-hit-mediated TGFβ-induced epithelial to mesenchymal transition in mammary epithelia.

Authors:  Edward J Richards; Gu Zhang; Zhu-Peng Li; Jennifer Permuth-Wey; Sridevi Challa; Yajuan Li; William Kong; Su Dan; Marilyn M Bui; Domenico Coppola; Wei-Min Mao; Thomas A Sellers; Jin Q Cheng
Journal:  J Biol Chem       Date:  2015-01-20       Impact factor: 5.157

7.  dbEMT: an epithelial-mesenchymal transition associated gene resource.

Authors:  Min Zhao; Lei Kong; Yining Liu; Hong Qu
Journal:  Sci Rep       Date:  2015-06-23       Impact factor: 4.379

  7 in total
  14 in total

1.  YAP promotes epithelial mesenchymal transition by upregulating Slug expression in human colorectal cancer cells.

Authors:  Dan Cheng; Lan Jin; Yunhe Chen; Xueyan Xi; Yang Guo
Journal:  Int J Clin Exp Pathol       Date:  2020-04-01

2.  Overexpression and Activation of αvβ3 Integrin Differentially Affects TGFβ2 Signaling in Human Trabecular Meshwork Cells.

Authors:  Mark S Filla; Kristy K Meyer; Jennifer A Faralli; Donna M Peters
Journal:  Cells       Date:  2021-07-29       Impact factor: 6.600

3.  Long non-coding RNA LINC00858 aggravates the oncogenic phenotypes of ovarian cancer cells through miR-134-5p/RAD18 signaling.

Authors:  Heng Xue; Zhihui Wu; Dongdong Rao; Bimin Zhuo; Qingquan Chen
Journal:  Arch Gynecol Obstet       Date:  2020-09-01       Impact factor: 2.344

4.  YAP1 contributes to NSCLC invasion and migration by promoting Slug transcription via the transcription co-factor TEAD.

Authors:  Mengxue Yu; Yingzhun Chen; Xuelian Li; Rui Yang; Lijia Zhang; Longtao Huangfu; Nan Zheng; Xiaoguang Zhao; Lifang Lv; Yaozhen Hong; Haihai Liang; Hongli Shan
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

5.  Systematic analyses reveal long non-coding RNA (PTAF)-mediated promotion of EMT and invasion-metastasis in serous ovarian cancer.

Authors:  Haihai Liang; Xiaoguang Zhao; Chengyu Wang; Jian Sun; Yingzhun Chen; Guoyuan Wang; Lei Fang; Rui Yang; Mengxue Yu; Yunyan Gu; Hongli Shan
Journal:  Mol Cancer       Date:  2018-06-21       Impact factor: 27.401

6.  LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression.

Authors:  Haihai Liang; Tong Yu; Yue Han; Hua Jiang; Chengyu Wang; Tianyi You; Xiaoguang Zhao; Huitong Shan; Rui Yang; Lida Yang; Hongli Shan; Yunyan Gu
Journal:  Mol Cancer       Date:  2018-08-11       Impact factor: 27.401

Review 7.  The Challenges and Opportunities of LncRNAs in Ovarian Cancer Research and Clinical Use.

Authors:  Martín Salamini-Montemurri; Mónica Lamas-Maceiras; Aida Barreiro-Alonso; Ángel Vizoso-Vázquez; Esther Rodríguez-Belmonte; María Quindós-Varela; María Esperanza Cerdán
Journal:  Cancers (Basel)       Date:  2020-04-21       Impact factor: 6.639

8.  Exosomal miR-128-3p Promotes Epithelial-to-Mesenchymal Transition in Colorectal Cancer Cells by Targeting FOXO4 via TGF-β/SMAD and JAK/STAT3 Signaling.

Authors:  Jian Bai; Xue Zhang; Dongdong Shi; Zhenxian Xiang; Shuyi Wang; Chaogang Yang; Qing Liu; Sihao Huang; Yan Fang; Weisong Zhang; Jialin Song; Bin Xiong
Journal:  Front Cell Dev Biol       Date:  2021-02-09

9.  EMTome: a resource for pan-cancer analysis of epithelial-mesenchymal transition genes and signatures.

Authors:  Suhas V Vasaikar; Abhijeet P Deshmukh; Petra den Hollander; Sridevi Addanki; Nick Allen Kuburich; Sriya Kudaravalli; Robiya Joseph; Jeffrey T Chang; Rama Soundararajan; Sendurai A Mani
Journal:  Br J Cancer       Date:  2020-12-10       Impact factor: 7.640

10.  Non-canonical signaling pathway of SNAI2 induces EMT in ovarian cancer cells by suppressing miR-222-3p transcription and upregulating PDCD10.

Authors:  Lili Fan; Han Lei; Sai Zhang; Yulong Peng; Chunyan Fu; Guang Shu; Gang Yin
Journal:  Theranostics       Date:  2020-04-27       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.